NO20032388D0 - Salter av et isotiazol-4-karboksamid og anvendelse derav som anti-hyperproliferasjonsmidler - Google Patents

Salter av et isotiazol-4-karboksamid og anvendelse derav som anti-hyperproliferasjonsmidler

Info

Publication number
NO20032388D0
NO20032388D0 NO20032388A NO20032388A NO20032388D0 NO 20032388 D0 NO20032388 D0 NO 20032388D0 NO 20032388 A NO20032388 A NO 20032388A NO 20032388 A NO20032388 A NO 20032388A NO 20032388 D0 NO20032388 D0 NO 20032388D0
Authority
NO
Norway
Prior art keywords
isothiazole
carboxamide
salts
hyperproliferative agents
hyperproliferative
Prior art date
Application number
NO20032388A
Other languages
English (en)
Other versions
NO20032388L (no
NO325187B1 (no
Inventor
Thomas G Gant
Glenn Robert Williams
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20032388D0 publication Critical patent/NO20032388D0/no
Publication of NO20032388L publication Critical patent/NO20032388L/no
Publication of NO325187B1 publication Critical patent/NO325187B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20032388A 2000-11-28 2003-05-27 Hydrobromidsalt og hemisuksinatsalt av et isotiazol-4-karboksamid samt anvendelse og fremstilling derav, og farmasoytisk preparat NO325187B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25351300P 2000-11-28 2000-11-28
PCT/IB2001/002193 WO2002044158A1 (en) 2000-11-28 2001-11-19 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Publications (3)

Publication Number Publication Date
NO20032388D0 true NO20032388D0 (no) 2003-05-27
NO20032388L NO20032388L (no) 2003-07-18
NO325187B1 NO325187B1 (no) 2008-02-11

Family

ID=22960587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032388A NO325187B1 (no) 2000-11-28 2003-05-27 Hydrobromidsalt og hemisuksinatsalt av et isotiazol-4-karboksamid samt anvendelse og fremstilling derav, og farmasoytisk preparat

Country Status (49)

Country Link
US (1) US6831091B2 (no)
EP (1) EP1337521B1 (no)
JP (2) JP2004514714A (no)
KR (2) KR20050116401A (no)
CN (1) CN1231474C (no)
AP (1) AP2001002358A0 (no)
AR (1) AR031512A1 (no)
AT (1) ATE340786T1 (no)
AU (2) AU1420402A (no)
BG (1) BG107752A (no)
BR (1) BR0115621A (no)
CA (1) CA2430065C (no)
CR (1) CR6963A (no)
CY (1) CY1106240T1 (no)
CZ (1) CZ20031315A3 (no)
DE (1) DE60123461T2 (no)
DK (1) DK1337521T3 (no)
DO (1) DOP2001000288A (no)
EA (1) EA005859B1 (no)
EC (1) ECSP034628A (no)
EE (1) EE200300247A (no)
ES (1) ES2271086T3 (no)
GE (1) GEP20053652B (no)
GT (1) GT200100237A (no)
HN (1) HN2001000268A (no)
HR (1) HRP20030408A2 (no)
HU (1) HUP0302553A3 (no)
IL (1) IL155371A0 (no)
IS (1) IS6788A (no)
MA (1) MA26960A1 (no)
MX (1) MXPA03004714A (no)
MY (1) MY136686A (no)
NO (1) NO325187B1 (no)
NZ (1) NZ525788A (no)
OA (1) OA12532A (no)
PA (1) PA8533801A1 (no)
PE (1) PE20020591A1 (no)
PL (1) PL362079A1 (no)
PT (1) PT1337521E (no)
SI (1) SI1337521T1 (no)
SK (1) SK5862003A3 (no)
SV (1) SV2002000748A (no)
TN (1) TNSN01167A1 (no)
TW (1) TWI287542B (no)
UA (1) UA74221C2 (no)
UY (1) UY27039A1 (no)
WO (1) WO2002044158A1 (no)
YU (1) YU36403A (no)
ZA (1) ZA200303341B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
AU2003281664A1 (en) * 2002-07-25 2004-02-16 Pfizer Products Inc. Isothiazole derivatives useful as anticancer agents
EP1545519B1 (en) * 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
DE602004007382T2 (de) 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
DK1663978T3 (da) 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
AU2004287416C1 (en) * 2003-10-27 2010-09-09 Merck Sharp & Dohme Corp. CCR-2 antagonist salt
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
WO2005102327A1 (en) * 2004-04-20 2005-11-03 Pfizer Products Inc. Dosage forms and methods of treatment using vegfr inhibitors
JP2007535565A (ja) 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体
TW200538104A (en) * 2004-05-17 2005-12-01 Pfizer Prod Inc Phenyl derivatives for the treatment of abnormal cell growth
US7550598B2 (en) 2004-08-18 2009-06-23 Takeda Pharmaceutical Company Limited Kinase inhibitors
DE602005023333D1 (de) 2004-10-15 2010-10-14 Takeda Pharmaceutical Kinaseinhibitoren
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
KR101627901B1 (ko) 2006-06-16 2016-06-13 하. 룬트벡 아크티에 셀스카브 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ht3 및 5-ht1a 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진
US7932390B2 (en) 2006-06-29 2011-04-26 Hoffman-La Roche Inc. Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
MX2010001636A (es) 2007-08-14 2010-03-15 Hoffmann La Roche Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
WO2011073521A1 (en) 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
SG187592A1 (en) 2010-07-23 2013-03-28 Univ Boston Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
KR102433489B1 (ko) * 2013-03-14 2022-08-17 팬옵티카, 인크. 눈의 후안부로의 약물 전달을 위한 안구용 제제
ES2863601T3 (es) * 2014-09-17 2021-10-11 Panoptica Inc Formulaciones oculares para administración de fármacos y protección del segmento anterior del ojo
TWI894754B (zh) * 2022-12-28 2025-08-21 大陸商蘇州必揚醫藥科技有限公司 一種蛋白酪胺酸激酶抑制劑及其醫藥用途
WO2026002133A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂的盐型
WO2026002142A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂的半琥珀酸盐晶型
WO2026002126A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂及其眼用制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця

Also Published As

Publication number Publication date
SI1337521T1 (sl) 2006-12-31
MY136686A (en) 2008-11-28
UY27039A1 (es) 2002-07-31
SV2002000748A (es) 2002-12-02
PA8533801A1 (es) 2002-10-31
HRP20030408A2 (en) 2003-08-31
JP4971946B2 (ja) 2012-07-11
CY1106240T1 (el) 2011-06-08
EE200300247A (et) 2003-10-15
ATE340786T1 (de) 2006-10-15
GT200100237A (es) 2002-07-03
AU2002214204B2 (en) 2007-05-24
CN1231474C (zh) 2005-12-14
NO20032388L (no) 2003-07-18
MA26960A1 (fr) 2004-12-20
JP2004514714A (ja) 2004-05-20
AU1420402A (en) 2002-06-11
EP1337521B1 (en) 2006-09-27
DK1337521T3 (da) 2007-01-29
DE60123461T2 (de) 2007-02-15
KR20050116401A (ko) 2005-12-12
PL362079A1 (en) 2004-10-18
EA005859B1 (ru) 2005-06-30
HUP0302553A2 (hu) 2003-11-28
CR6963A (es) 2003-11-25
HK1059085A1 (en) 2004-06-18
EA200300424A1 (ru) 2003-10-30
EP1337521A1 (en) 2003-08-27
DE60123461D1 (de) 2006-11-09
TWI287542B (en) 2007-10-01
BG107752A (bg) 2004-01-30
YU36403A (sh) 2006-08-17
US20020151573A1 (en) 2002-10-17
NZ525788A (en) 2004-11-26
GEP20053652B (en) 2005-11-10
CN1476439A (zh) 2004-02-18
CZ20031315A3 (cs) 2004-04-14
IS6788A (is) 2003-04-14
CA2430065A1 (en) 2002-06-06
BR0115621A (pt) 2003-09-02
US6831091B2 (en) 2004-12-14
HN2001000268A (es) 2002-01-30
CA2430065C (en) 2008-05-20
AR031512A1 (es) 2003-09-24
NO325187B1 (no) 2008-02-11
OA12532A (en) 2006-06-02
ES2271086T3 (es) 2007-04-16
HUP0302553A3 (en) 2009-03-30
PE20020591A1 (es) 2002-07-06
PT1337521E (pt) 2006-12-29
TNSN01167A1 (fr) 2005-11-10
ECSP034628A (es) 2003-07-25
AP2001002358A0 (en) 2001-12-31
IL155371A0 (en) 2003-11-23
SK5862003A3 (en) 2004-05-04
UA74221C2 (uk) 2005-11-15
WO2002044158A1 (en) 2002-06-06
JP2008056692A (ja) 2008-03-13
DOP2001000288A (es) 2002-12-15
ZA200303341B (en) 2004-04-30
MXPA03004714A (es) 2003-08-19
KR20030059275A (ko) 2003-07-07

Similar Documents

Publication Publication Date Title
NO20032388L (no) Salter av et isotiazol-4-karboksamid og anvendelse derav som anti-hyperproliferasjonsmidler
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1268481T3 (da) Inaseinkibitorer som terapeutiske midler
DK1282611T3 (da) Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
NO20023713D0 (no) 2-benzotiazolyl-urea-derivater samt anvendelse derav som proteinkinaseinhibitorer
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20030867L (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20020383L (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20044062L (no) N-aryl-2-oksazolidinon-5-karboksamider og deres derivater og deres anvendelse som antibakterielle midler
NO2011002I2 (no) Regadenoson og salter derav
NO20034439D0 (no) Benzamidinderivater
NO20025150L (no) 2-acylindolderivater og deres anvendelse som antitumormidler
NO20034177L (no) Pyrazolopyrimidiner som terapeutiske midler
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DE50110553D1 (de) Verwendung herbizider Mittel
NO20024838L (no) Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20021007D0 (no) Substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-oner og deres anvendelse som lipasehemmere
NO20030998D0 (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler